Category Archives: U.S. Policy and Funding

Global health advocates suggest alternatives when limited options + limited bargaining power = unlimited drug prices

By on .

Around the time the price of Daraprim, a drug used to treat toxoplasmosis rose by 5000 percent last month, the panel that produces federally approved guidelines for prevention and treatment of opportunistic infections in people living with HIV issued a heads up to physicians in the United States. They might need to consider substitute options […]

Antibiotic resistance poses growing threat to fragile health systems

By on .

While one of the most significant life-saving medical breakthroughs of the last century, the use of antibiotics to fight and prevent infections is becoming one of the greatest medical challenges in this century, including, at growing rates, in countries least equipped to monitor and respond to new health threats, a report released today says. The […]

Once again, “Ebola-free,” Liberia begins three months of surveillance, while Guinea and Sierra Leone see dwindling crisis, continued challenges, and CDC looks ahead

By on .

A medical student in Guinea doesn’t reveal that he was exposed to Ebola when he’s admitted to a Conakry hospital, where he then shares a room. By the time he is diagnosed with the virus, a visitor of the roommate has fallen ill and taken a dozen taxis to a series of doctors and hospitals, transmitting […]

One more reason global health news matters: Ebola reporting provides real time data

By on .

By the time the World Health Organization learned of an Ebola outbreak sparked in December 2013, when a bat likely transmitted the virus to a child playing in a tree, nearly four months had passed and the disease had spread across three countries in West Africa. In the process of the response that followed, information that could […]